Legal Representation
Attorney
Christina M. Licursi, Esq.
USPTO Deadlines
Next Deadline
110 days remaining
NOA E-Mailed - SOU Required
Due Date
April 10, 2026
Extension Available
Until October 10, 2026
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 9, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 9, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 10, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 10, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 10, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 10, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 10, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 10, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 11, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 10, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 10, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 10, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 29, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 29, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 10, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 15, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 15, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 26, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 11, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 11, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 11, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 11, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 10, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 30, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 16, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 15, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 15, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 16, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 16, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 16, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 10, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 26, 2022 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Oct 26, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| May 3, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 2, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 28, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer
Class 042
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
Class 044
Medical diagnostic services for use in the treatment and diagnosis of cancer
Additional Information
Design Mark
The mark consists of nine shaded circles forming a square, where the top and bottom circles in the middle row are of smaller size, followed by the stylized wording "HARBINGER HEALTH".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTH"